The (pro)renin receptor in health and disease

References

• Varagic J, Trask AJ, Jessup JA, Chappell MC, Ferrario CM. New angiotensins. J Mol Med. 2008; 86:663–71.
   PubMed Web of Science ®Google Scholar
• Danser AHJ, Deinum J. Renin, prorenin and the putative (pro)renin receptor. Hypertension. 2005; 46:1069–76.
   PubMed Web of Science ®Google Scholar
• van den Heuvel M, Batenburg WW, Danser AH. Diabetic complications: a role for the prorenin-(pro)renin receptor-TGF-beta1 axis? Mol Cell Endocrinol. 2009; 302:213–8.
   PubMed Web of Science ®Google Scholar
• Methot D, Silversides DW, Reudelhuber TL. In vivo enzymatic assay reveals catalytic activity of the human renin precursor in tissues. Circ Res. 1999; 8:1067–72.
   Google Scholar
• Danser AHJ, Derkx FHM, Schalekamp MADH, Hense HW, Riegger GAJ, Schunkert H. Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans. J Hypertens. 1998; 16:853–62.
   PubMed Web of Science ®Google Scholar
• Sealey JE, Glorioso N, Itskovitz J, Atlas SA, Pitarresi TM, Preibisz JJ, . Ovarian prorenin. Clin Exp Hypertens A. 1987; 9:1435–54.
   PubMed Web of Science ®Google Scholar
• Lumbers ER. Functions of the renin-angiotensin system during development. Clin Exp Pharmacol Physiol. 1995; 22:499–505.
   PubMed Web of Science ®Google Scholar
• Itskovitz J, Rubattu S, Levron J, Sealey JE. Highest concentrations of prorenin and human chorionic gonadotropin in gestational sacs during early human pregnancy. J Clin Endocrinol Metab. 1992; 75:906–10.
   PubMed Web of Science ®Google Scholar
• Takimoto-Ohnishi E, Saito T, Ishida J, Ohnishi J, Sugiyama F, Yagami K, . Differential roles of renin and angiotensinogen in the feto-maternal interface in the development of complications of pregnancy. Mol Endocrinol. 2005; 19:1361–72.
   PubMedGoogle Scholar
• Anton L, Brosnihan KB. Systemic and uteroplacental renin– angiotensin system in normal and pre-eclamptic pregnancies. Ther Adv Cardiovasc Dis. 2008; 2:349–62.
   PubMedGoogle Scholar
• Price DA, Porter LE, Gordon M, Fisher ND, De’Oliveira JM, Laffel LM, . The paradox of the low-renin state in diabetic nephropathy. J Am Soc Nephrol. 1999; 10:2382–91.
   PubMed Web of Science ®Google Scholar
• Kelly DJ, Zhang Y, Moe G, Naik G, Gilbert RE. Aliskiren, a novel renin inhibitor, is renoprotective in a model of advanced diabetic nephropathy in rats. Diabetologia. 2007; 50:2398–404.
   PubMed Web of Science ®Google Scholar
• Luetscher JA, Kraemer FB, Wilson DM, Schwartz HC, Bryer-Ash M. Increased plasma inactive renin in diabetes mellitus. A marker of microvascular complications. N Engl J Med. 1985; 312:1412–7.
   PubMed Web of Science ®Google Scholar
• Wilson DM, Luetscher JA. Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus. N Engl J Med. 1990; 323:1101–6.
   PubMed Web of Science ®Google Scholar
• Deinum J, Ronn B, Mathiesen E, Derkx FHM, Hop WC. Schalekamp MADH. Increase in serum prorenin precedes onset of microalbuminuria in patients with insulin-dependent diabetes mellitus. Diabetologia. 1999; 42:1006–10.
   PubMed Web of Science ®Google Scholar
• Peters B, Grisk O, Becher B, Wanka H, Kuttler B, Ludemann J, . Dose-dependent titration of prorenin and blood pressure in Cyp1a1ren-2 transgenic rats: absence of prorenin-induced glomerulosclerosis. J Hypertens. 2008; 26:102–9.
   PubMed Web of Science ®Google Scholar
• Mercure C, Prescott G, Lacombe MJ, Silversides DW, Reudelhuber TL. Chronic increases in circulating prorenin are not associated with renal or cardiac pathologies. Hypertension. 2009; 53:1062–9.
   PubMed Web of Science ®Google Scholar
• Nguyen G, Delarue F, Burcklé C, Bouzhir L, Giller T, Sraer J-D. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest. 2002; 109:1417–27.
   PubMed Web of Science ®Google Scholar
• Cousin C, Bracquart D, Contrepas A, Corvol P, Muller L, Nguyen G. Soluble form of the (pro)renin receptor generated by intracellular cleavage by furin is secreted in plasma. Hypertension. 2009; 53:1077–82.
   PubMed Web of Science ®Google Scholar
• Batenburg WW, Krop M, Garrelds IM, de Vries R, de Bruin RJA, Burcklé C, . Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor. J Hypertens. 2007; 25:2441–53.
   PubMed Web of Science ®Google Scholar
• Nabi AHMN, Kageshima A, Uddin MN, Nakagawa T, Park EY, Suzuki F. Binding properties of rat prorenin and renin to the recombinant rat renin/prorenin receptor prepared by a baculovirus expression system. Int J Mol Med. 2006; 18:483–8.
   PubMed Web of Science ®Google Scholar
• Huang Y, Wongamorntham S, Kasting J, McQuillan D, Owens RT, Yu L, . Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int. 2006; 69:105–13.
   PubMed Web of Science ®Google Scholar
• Huang Y, Noble NA, Zhang J, Xu C, Border WA. Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells. Kidney Int. 2007; 72:45–52.
   PubMed Web of Science ®Google Scholar
• Huang Y, Border WA, Noble NA. Functional renin receptors in renal mesangial cells. Curr Hypertens Rep. 2007; 9:133–9.
   PubMed Web of Science ®Google Scholar
• Feldt S, Batenburg WW, Mazak I, Maschke U, Wellner M, Kvakan H, . Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide. Hypertension. 2008; 51:682–8.
   PubMed Web of Science ®Google Scholar
• Ichihara A, Suzuki F, Nakagawa T, Kaneshiro Y, Takemitsu T, Sakoda M, . Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol. 2006; 7:1950–61.
   Google Scholar
• Saris JJ, ‘t Hoen PA, Garrelds IM, Dekkers DHW, den Dunnen JT, Lamers JMJ, . Prorenin induces intracellular signaling in cardiomyocytes independently of angiotensin II. Hypertension. 2006; 48:564–71.
   PubMed Web of Science ®Google Scholar
• Schefe JH, Menk M, Reinemund J, Effertz K, Hobbs RM, Pandolfi PP, . A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein. Circ Res. 2006; 99:1355–66.
   PubMed Web of Science ®Google Scholar
• Kaneshiro Y, Ichihara A, Sakoda M, Takemitsu T, Nabi AH, Uddin MN, . Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats. J Am Soc Nephrol. 2007; 18:1789–95.
   PubMed Web of Science ®Google Scholar
• Burcklé CA, Danser AHJ, Müller DN, Garrelds IM, Gasc JM, Popova E, . Elevated blood pressure and heart rate in human renin receptor transgenic rats. Hypertension. 2006; 47:552–56.
   PubMed Web of Science ®Google Scholar
• Krebs C, Hamming I, Sadaghiani S, Steinmetz OM, Meyer-Schwesinger C, Fehr S, . Antihypertensive therapy upregulates renin and (pro)renin receptor in the clipped kidney of Goldblatt hypertensive rats. Kidney Int. 2007; 72:725–30.
   PubMed Web of Science ®Google Scholar
• Krebs C, Weber M, Steinmetz O, Meyer-Schwesinger C, Stahl R, Danser AH, . Effect of (pro)renin receptor inhibition by a decoy peptide on renal damage in the clipped kidney of Goldblatt rats. Kidney Int. 2008; 74:823–24.
   PubMed Web of Science ®Google Scholar
• Siragy HM, Huang J. Renal (pro)renin receptor upregulation in diabetic rats through enhanced angiotensin AT1 receptor and NADPH oxidase activity. Exp Physiol. 2008; 93:709–14.
   PubMed Web of Science ®Google Scholar
• Suzuki F, Hayakawa M, Nakagawa T, Nasir UM, Ebihara A, Iwasawa A, . Human prorenin has ‘gate and handle’ regions for its non-proteolytic activation. J Biol Chem. 2003; 278:22217–22.
   PubMed Web of Science ®Google Scholar
• Mercure C, Thibault G, Lussier-Cacan S, Davignon J, Schiffrin EL, Reudelhuber TL. Molecular analysis of human prorenin prosegment variants in vitro and in vivo. J Biol Chem. 1995; 270:16355–9.
   PubMed Web of Science ®Google Scholar
• Ichihara A, Hayashi M, Kaneshiro Y, Suzuki F, Nakagawa T, Tada Y, . Inhibition of diabetic nephropathy by a decoy peptide corresponding to the ‘handle’ region for nonproteolytic activation of prorenin. J Clin Invest. 2004; 114:1128–35.
   PubMed Web of Science ®Google Scholar
• Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Suzuki F, Nakagawa T, . Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension. 2006; 47:894–900.
   PubMed Web of Science ®Google Scholar
• Takahashi H, Ichihara A, Kaneshiro Y, Inomata K, Sakoda M, Takemitsu T, . Regression of nephropathy developed in diabetes by (Pro)renin receptor blockade. J Am Soc Nephrol. 2007; 18:2054–61.
   PubMed Web of Science ®Google Scholar
• Satofuka S, Ichihara A, Nagai N, Koto T, Shinoda H, Noda K, . Role of nonproteolytically activated prorenin in pathologic, but not physiologic, retinal neovascularization. Invest Ophthalmol Vis Sci. 2007; 48:422–9.
   PubMed Web of Science ®Google Scholar
• Satofuka S, Ichihara A, Nagai N, Yamashiro K, Koto T, Shinoda H, . Suppression of ocular inflammation in endotoxin-induced uveitis by inhibiting nonproteolytic activation of prorenin. Invest Ophthalmol Vis Sci. 2006; 47:2686–92.
   PubMed Web of Science ®Google Scholar
• Satofuka S, Ichihara A, Nagai N, Noda K, Ozawa Y, Fukamizu A, . (Pro)renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation. Diabetes. 2009; 58:1625–33.
   PubMed Web of Science ®Google Scholar
• Müller DN, Klanke B, Feldt S, Cordasic N, Hartner A, Schmieder RE, . (Pro)renin receptor peptide inhibitor ‘handle-region’ peptide does not affect hypertensive nephrosclerosis in Goldblatt rats. Hypertension. 2008; 51:676–81.
   PubMed Web of Science ®Google Scholar
• Feldt S, Maschke U, Dechend R, Luft FC, Muller DN. The putative (pro)renin receptor blocker HRP fails to prevent (pro)renin signaling. J Am Soc Nephrol. 2008; 19:743–8.
   PubMed Web of Science ®Google Scholar
• Ludwig J, Kerscher S, Brandt U, Pfeiffer K, Getlawi F, Apps DK, . Identification and characterization of a novel 9.2-kDa membrane sector-associated protein of vacuolar proton-ATPase from chromaffin granules. J Biol Chem. 1998; 273:10939–47.
   PubMed Web of Science ®Google Scholar
• Nishi T, Forgac M. The vacuolar (H+)-ATPases—nature's most versatile proton pumps. Nat Rev Mol Cell Biol. 2002; 3:94–103.
   PubMed Web of Science ®Google Scholar
• Amsterdam A, Nissen RM, Sun Z, Swindell EC, Farrington S, Hopkins N. Identification of 315 genes essential for early zebrafish development. Proc Natl Acad Sci U S A. 2004; 101:12792–7.
   PubMed Web of Science ®Google Scholar
• Advani A, Kelly DJ, Cox AJ, White KE, Advani SL, Thai K, . The (pro)renin receptor. Site-specific and functional linkage to the vacuolar H+-ATPase in the kidney. Hypertension. 2009; 54:261–9.
   PubMed Web of Science ®Google Scholar
• Sigmund CD, Gross KW. Structure, expression, and regulation of the murine renin genes. Hypertension. 1991; 18:446–57.
   PubMed Web of Science ®Google Scholar
• Contrepas A, Praizovic N, Duong Van Huyen JP, Lelievre-Pegorier M, Corvol P, Nguyen G. Expression of (pro)renin receptor in mouse embryonic and newborn kidney and proliferative effect of soluble (P)RR on mesangial cells. Hypertension. 2007; 50:e145. (Abstract).
   Web of Science ®Google Scholar
• Ramser J, Abidi FE, Burckle CA, Lenski C, Toriello H, Wen G, . A unique exonic splice enhancer mutation in a family with X-linked mental retardation and epilepsy points to a novel role of the renin receptor. Hum Mol Genet. 2005; 14:1019–27.
   PubMed Web of Science ®Google Scholar
• Contrepas A, Walker J, Koulakoff A, Franek KJ, Qadri F, Giaume CB, . A role of the (pro) renin receptor in neuronal cell differentiation. Am J Physiol Regul Integr Comp Physiol. 2009; 297:R250–7.
   PubMed Web of Science ®Google Scholar
• L’Huillier N, Sharp MGF, Dunbar DR, Mullins JJ. On the relationship between the renin receptor and the vacuolar proton ATPase membrane sector associated protein (M8-9). The local cardiac renin angiotensin-aldosterone system. Frolich ED, Re RN. Springer; 2005. 17–34.
   Google Scholar
• Burcklé C, Bader M. Prorenin and its ancient receptor. Hypertension. 2006; 48:549–51.
   PubMed Web of Science ®Google Scholar
• Bader M. The second life of the (pro)renin receptor. J Renin Angiotensin Aldosterone Syst. 2007; 8:205–8.
   PubMed Web of Science ®Google Scholar
• Tigerstedt R, Bergman PG. Niere und Kreislauf. Skand Arch Physiol. 1898; 8:223–71.
   Google Scholar